Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
Close

Search

  • https://www.facebook.com/
  • https://twitter.com/
  • https://t.me/
  • https://www.instagram.com/
  • https://youtube.com/
Subscribe
Home/News/Groundbreaking FDA Approval: Elon Musk’s Neuralink Vision Implant Offers New Hope for the Blind | Tech News
News

Groundbreaking FDA Approval: Elon Musk’s Neuralink Vision Implant Offers New Hope for the Blind | Tech News

By adminitfy
September 18, 2024 1 Min Read

Elon Musk’s brain-chip company, Neuralink, has achieved a major milestone by securing the US Food and Drug Administration’s (FDA) ‘breakthrough device’ designation for its innovative vision-restoring implant, Blindsight. This designation is granted to medical advancements that offer treatment for life-threatening or severely debilitating conditions, aiming to expedite their development and review processes.

Blindsight is designed to help individuals who have lost both eyes and their optic nerves regain vision. Musk announced on social platform X (formerly Twitter) that this device will allow people who have been blind since birth to see, provided their visual cortex is intact. Nonetheless, Neuralink has not yet specified when human trials will commence.

Founded in 2016 by Musk and a team of engineers, Neuralink is focused on developing brain-chip interfaces that can be implanted within the skull. These chips aim to assist patients with disabilities in moving, communicating, and now potentially restoring vision by processing and transmitting neural signals to external devices like computers and smartphones.

In a parallel venture, Neuralink is also working on another implant designed to help paralyzed patients control digital devices merely through their thoughts. This is set to be tested in a trial involving three patients over several years. Earlier this year, the company successfully implanted a brain-chip in a second patient, who is now using it to play video games and learn 3D design—offering a tantalizing glimpse into the future applications of brain-computer interfaces.

[With agency inputs]

First Published: Sep 18, 2024 | 10:40 AM IST

Original Story https://www.business-standard.com/technology/tech-news/elon-musk-s-neuralink-gains-fda-breakthrough-tag-for-vision-implant-124091800250_1.html
Category :
Tags:

Author

adminitfy

Follow Me
Other Articles
Previous

Unforgettable Journey Awaits: Ziro Music Festival in Arunachal Pradesh to Enchant Audiences – Northeast News Exclusive

Next

Crucial Peace of Mind: Why Timely Car Insurance Renewal is Your Lifeline

Search...

Recent Posts

  • Drizzle No Bar as Urban Challenge Opens to Packed DDSC Gallery
    Drizzle No Bar as Urban Challenge Opens to Packed DDSC Gallery
    by adminitfy
    November 21, 2026
  • Empowering Northeast India: CII’s CSR Connect Event Ignites Social Development
    by adminitfy
    July 3, 2024
  • Urgent Crisis: Northeast on High Alert as Death Toll Tragically Rises in Assam
    by adminitfy
    July 3, 2024
  • Triumphant Breakthrough: Security Forces Successfully Capture 4 Insurgents in Manipur Operation
    by adminitfy
    July 3, 2024

Welcome to the ultimate source for fresh perspectives! Explore curated content to enlighten, entertain and engage global readers.

  • Facebook
  • X
  • Instagram
  • LinkedIn

Latest Posts

  • Drizzle No Bar as Urban Challenge Opens to Packed DDSC Gallery
  • Exclusive: Ajay Devgn & Bhushan Kumar’s 2028 Big-Budget Spy Thriller Talks Spark Blockbuster Buzz!
  • 49th Junior National Badminton Championships End with Grand Closing
  • Manipur: Kangpokpi Warns Against Local Liquor After Suspected Deaths
  • Scrub Typhus Kills 68-Year-Old Man in Assam’s Bongaigaon
  • November 2026 (669)
  • October 2026 (646)
  • September 2026 (524)
  • August 2026 (1001)
  • July 2026 (986)
  • June 2026 (963)
  • May 2026 (922)
  • April 2026 (1525)
  • March 2026 (1522)
  • February 2026 (1252)
  • January 2026 (968)
  • December 2025 (942)
  • November 2025 (853)
  • October 2025 (869)
  • September 2025 (733)
  • August 2025 (810)
  • July 2025 (720)
  • June 2025 (1244)
  • May 2025 (2201)
  • April 2025 (1481)
  • March 2025 (2020)
  • February 2025 (1159)
  • January 2025 (1440)
  • December 2024 (1499)
  • November 2024 (1771)
  • October 2024 (1815)
  • September 2024 (1750)
  • August 2024 (1458)
  • July 2024 (1268)

Contact

Email

info@itfy.in

Location

INDIA

Copyright 2026 — Itfy.in. All rights reserved.